Project Grant R43TR005404
Award Date 8/1/25
Completion Date 7/31/26
Dollars Obligated $329K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
San Diego, CA 92121, USA
Similar Awards
- This National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) Project Grant award of $285,444, effective August 15, 2025 through August 14, 2026 (CFDA 93.350), aims to develop recombinant human enzyme panels representing genetic variants of drug-metabolizing enzymes present in the U.S. patient population. The goal is to bridge shortcomings in current in vitro drug metabolism testing, which typically relies on liver microsomes or hepatocytes from...
- This federal Project Grant award of $348,848 was provided by the National Center for Advancing Translational Sciences (NCATS) under the CFDA program 93.350 - National Center for Advancing Translational Sciences. The grant aims to diversify the cyclization positions in mRNA display libraries, a method of rapidly generating large protein-peptide binding datasets and discovering novel peptide therapeutics. The funded work will leverage a new approach called Segmented In Vitro Translation (SIVT)...
- The National Center for Advancing Translational Sciences (NCATS) awarded a $1,050,276 Project Grant to Syntr Health Technologies, Inc. on September 25, 2025 under the CFDA 93.350 Federal Grant Program. This funding supports the development and automation of an FDA-cleared CD-microfluidic platform for rapid tissue microsizing. The platform technology can process a variety of tissue types, including cancer tumors and adipose tissue, to enable single-cell analysis and regenerative medical...
- This $412,632 Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports research to advance the biocatalytic synthesis of complex medicinal small molecules. The award, with a performance period from August 1, 2025 to July 31, 2030, will fund the development of computer-aided synthesis planning (CASP) tools to generalize known enzymatic reactions and predict routes for producing...
- This federal Project Grant award, funded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports the development and validation of an innovative assay for measuring and targeting the drug target sphingosine kinase (SphK) in cancer cells. Piccolo Biosystems, Inc., an early-stage biotechnology company, will collaborate with scientists at the University of Washington to leverage their patent-pending...
- This federal Project Grant award from the National Center for Advancing Translational Sciences (NCATS) under CFDA 93.350 provides $406,500.00 to Syntr Health Technologies, Inc. to develop an automated, microfluidic tissue dissociation platform called the SYNTRFUGE. This device aims to rapidly and efficiently process solid tumor tissue samples into single cells for diagnostic analysis and research, addressing a critical barrier to more widespread use of single-cell analysis in oncology. The...
- This federal Project Grant award of $322,388.00 from the National Center for Advancing Translational Sciences (NCATS), under CFDA 93.350, will support the "Production of Stimulated Emission-Encoded Beads for Large Molecular Library Generation" at Spectral Therapeutics, Inc. in California. The project aims to develop an optical-encoded library technology capable of encoding diverse molecular libraries and decoding them instantaneously during assay readout. The technology will involve...
- The National Institute of General Medical Sciences (NIGMS) awarded a $306,872 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Fluid Discovery, Inc., a San Francisco-based biotechnology company, to develop a "Universal Platform for Ultrahigh-Throughput Biocatalyst Evolution with Micro-Mass Spectrometry." The award supports the development of a commercial prototype for Fluid Discovery's novel screening platform, which combines scalable hardware,...
- The National Center for Advancing Translational Sciences (NCATS), under the CFDA Program 93.350, awarded a $338,997 Project Grant to Mabswitch Inc. effective January 1, 2024 to December 31, 2024. The project aims to develop "LENTISAFE LIGANDS: MILD-ELUTION IMMUNOAFFINITY LIGANDS FOR ENRICHMENT AND PURIFICATION OF LENTIVIRAL VECTORS." The goal is to create switchable affinity ligands that can be used to selectively isolate and enrich functional lentiviral vectors from production...
- This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) is intended to support the development and validation of a chemically induced dimerization (CID) system capable of detecting nanomolar concentrations of coenzyme A (CoA) in the presence of excess acetyl-CoA. This CID system is being created to provide a universal assay method for screening histone acetyltransferases, which are important...